Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
35.94
-0.48 (-1.32%)
At close: Jun 18, 2026, 4:00 PM EDT
35.98
+0.04 (0.11%)
After-hours: Jun 18, 2026, 7:59 PM EDT
Medline Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Medline stock has a consensus rating of "Buy" and an average price target of $51.15. The average 1-year stock price forecast is 42.32% higher than the current stock price, while the lowest is $40 (+11.30%) and the highest is $62 (+72.51%).
Price Target: $51.15 (+42.32%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Medline stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 16 | 17 | 17 | 17 | 17 |
| Buy | 5 | 6 | 6 | 6 | 7 | 7 |
| Hold | 4 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 27 | 28 | 28 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 12, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $56 → $52 | Buy | Maintains | $56 → $52 | +44.69% | Jun 12, 2026 |
| BTIG | BTIG | Buy Reiterates $55 | Buy | Reiterates | $55 | +53.03% | Jun 9, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $45 | Buy | Maintains | $45 | +25.21% | Jun 2, 2026 |
| Barclays | Barclays | Buy Reiterates $50 → $45 | Buy | Reiterates | $50 → $45 | +25.21% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
31.09B
from 28.43B
Increased by 9.33%
Revenue Next Year
34.97B
from 31.09B
Increased by 12.48%
EPS This Year
1.51
from 1.79
Decreased by -15.84%
EPS Next Year
1.67
from 1.51
Increased by 10.51%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 31.2B | ||
| Avg | 31.1B | ||
| Low | 31.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.8% | ||
| Avg | 9.3% | ||
| Low | 8.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.62 | ||
| Avg | 1.51 | ||
| Low | 1.44 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -9.7% | ||
| Avg | -15.8% | ||
| Low | -20.0% |